FDA Inspection 1215625 — Biomat USA Inc
The FDA completed an inspection of Biomat USA Inc on August 10, 2023 in Williamsport, PA. The inspection was classified NAI (No Action Indicated — no objectionable conditions were found). Product area: Biologics.
Inspection Details
- Classification
- No Action Indicated (NAI) (NAI)
- End Date
- August 10, 2023
- Fiscal Year
- 2023
- Product Type
- Biologics
- Project Area
- Blood and Blood Products
- Location
- Williamsport, PA (United States)